Concepedia

Publication | Closed Access

The cancer stem cell antigens CD133, BCRP1/ABCG2 and CD117/c-KIT are not associated with prognosis in resected early-stage non-small cell lung cancer.

46

Citations

30

References

2011

Year

Esther Herpel, Katrin Jensen, Thomas Muley, Arne Warth, Philipp A. Schnabel, Michael Meister, Felix Herth, Hendrik Dienemann, Michael Thomas, Sandra Gottschling
PubMed

Abstract

In resected early-stage NSCLC, CSC antigens show no association with prognosis. However, in patients with relapse and tumors >3 cm, expression of CD117 might predict worse OS.

References

YearCitations

Page 1